Stem Cell Therapeutic and Research Reauthorization Act of 2025
Download PDFSponsored by
Rep. Smith, Christopher H. [R-NJ-4]
ID: S000522
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
May 20, 2026
Introduced
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
Committee Review
Floor Action
Passed House
Senate Review
Passed Congress
Presidential Action
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 5160 Introduced in House (IH)]
<DOC>
119th CONGRESS 1st Session H. R. 5160
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 4, 2025
M...
💰 Campaign Finance Network
No campaign finance data available for Rep. Smith, Christopher H. [R-NJ-4]
Cosponsors & Their Campaign Finance
This bill has 10 cosponsors. Below are their top campaign contributors.
Rep. Matsui, Doris O. [D-CA-7]
ID: M001163
Top Contributors
10
Rep. Bilirakis, Gus M. [R-FL-12]
ID: B001257
Top Contributors
10
Rep. Pingree, Chellie [D-ME-1]
ID: P000597
Top Contributors
10
Rep. Tenney, Claudia [R-NY-24]
ID: T000478
Top Contributors
10
Rep. Mfume, Kweisi [D-MD-7]
ID: M000687
Top Contributors
10
Rep. Fischbach, Michelle [R-MN-7]
ID: F000470
Top Contributors
10
Rep. Dingell, Debbie [D-MI-6]
ID: D000624
Top Contributors
10
Rep. Gottheimer, Josh [D-NJ-5]
ID: G000583
Top Contributors
10
Rep. Aderholt, Robert B. [R-AL-4]
ID: A000055
Top Contributors
10
Rep. Malliotakis, Nicole [R-NY-11]
ID: M000317
Top Contributors
10
Donor Network - Rep. Smith, Christopher H. [R-NJ-4]
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 19 nodes and 15 connections
Total contributions: $106,315
Industry Impact
Which industries are materially affected by specific provisions in this bill. 2 helped.
- +Biotech & Research confidence 0.90
Section 2 reauthorizes funding for the C.W. Bill Young Cell Transplantation Program, increasing appropriations from $31,009,000 to $33,009,000 for FY 2027-2031, providing a clear benefit to biotech and research firms involved in stem cell therapeutics.
- +Hospitals & Health Systems confidence 0.85
Section 3 extends the cord blood inventory deadline from 2026 to 2031, supporting hospitals and health systems that collect, store, and use cord blood for transplants, representing a market expansion.